Jump to content

Aceprometazine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Anypodetos (talk | contribs) at 18:43, 29 April 2009 (ATC_prefix=none). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

{{drugbox | | IUPAC_name = 1-{10-[2-(dimethylamino)propyl]-10H-phenothiazin-2-yl}ethanone | image = Aceprometazine.svg | CAS_number = 13461-01-3 | ATC_prefix = none | ATC_suffix = | PubChem = 26035 | DrugBank = DB01615 | C = 19 | H = 22 | N = 2 | O = 1 | S = 1 | molecular_weight = 326.456 g/mol | smiles = CC(=O)c1cc2N(CC(C)N(C)C)c3ccccc3Sc2cc1 | bioavailability = | protein_bound = | metabolism = Hepatic | elimination_half-life = | excretion = Renal and fecal | pregnancy_category = Contraindicated
Passes into breast milk | legal_status = Rx-only | routes_of_administration = Oral }} Aceprometazine (INN) is a prescription drug with neuroleptic and anti-histamine properties. It is not widely prescribed. It may be used in combination with meprobamate for the treatment of sleep disorders. This combination is available in France under the trade name Mepronizine.